Important Role of P-Selectin for Leukocyte Recruitment, Hepatocellular Injury, and Apoptosis in Endotoxemic Mice//Clin. Vaccine Immunol..- January 1.- 2004.-V.11(1).-P. 56 - 62
Kluck R.M., Bossy-Wetzel E., Green D.R. et al. The release of cytochrome с from mitochondria: a primary she for Bcl-2 regulation of apoptosis // Science, - 1997. - Vol. 275.-P. 1132-1136
Kountouras J., Chatzopoulos D., Zavos C. Apoptosis in hepatitis C // J. Viral Hepatitis. – 2003. – Vol. 10. – P. 335–342
Krammer P. H. CD95's deadly mission in the immune system // Nature. - 2000. -Vol. 407. - P. 789-795
Krueger A., Baumann S., Krammer P. H„ Kirchhoff S. FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis // Molecular and cellular biology. - 2001. - Vol. 21. - N. 24. - P. 8247-8254
Kuwano K., Kunitake R., Kawasaki M. et al. P21/Cip/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulnonary fibrosis. Am J Responce Crit Care Med 1996; 154: 477-483
Kuwashima Y., Kobayashi Y., Kawarai A. et al. Apoptosis in human endometrial adenocarcinoma: comparison of nick end labeling and Le(y) antigen immunostaining method. Anticancer Res 1996; 16: 5B: 3225-3228
Kuwashima Y., Kobayashi Y., Kawarai A. et al. Expression of bcl-2 and apoptotic DNA fragmentation in human endometrial adenocarcinoma cells. Anticancer Res 1996; 16: 5B: 3221- 3224
Kuwashima Y., Kobayashi Y., Kawarai A. et al. Occurrence of apoptotic DNA fragmentation in quiescent and proliferating cells in human endometrial adenocarcinoma tissues and the influence of apoptosis-suppressing effects of bcl-2 products. Anticancer Res 1997; 17: 5B: 3737-3741
Lafon C., Mathieu C., Guerrin M. et al. Transforming growth factor beta 1-induced apoptosis in human ovarian carcinoma cells: protection by the antioxidant N-acetylcysteine and bcl-2. Cell Growth Differ 1996; 7: 8: 1095-1104
Lam M., Bhat M. В., Nunez G, et al. Regulation of Bcl-XL channel activity by calcium // The journal of biological chemistry. - 1998. - Vol. 273. - N. 28. - P. 17307-17310
Levine E.L., Renehan A., Gossiel R. et al. Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma. Radiother Oncol 1995; 37: 1: 1-9
Li X. K., Okuyama ., Tamura A. et al. Prolonged survival of recipient rats with Fas-ligand-transfected liver allografts by using HVJ-liposome // Transplant. Proc. — 1998, —Vol. 30, N4
Liang Y., Nylander K. D,, Yan C, Schor N. F. Role of caspase 3-dependent Bcl-2 cleavage in potentiation of apoptosis by Bcl-2 // Mol. Pharmacol. - 2002. - Vol. 61. - P. 142-149
Lian-Jun Y., Wen-Liang W. Expression of Bcl-2 and Bax proteins in hepatocellular carcinoma tissue // J. Fourth Mil. Med. Univ. - 2002. - Vol. 23. - P. 337-340
Liu X,-H., CasteUi J. C, Youle R. J. Receptor-mediated uptake of an extracellular Bcl-XL fusion protein inhibits apoptosis // Proc. Natl. Acad. Sci. USA. - 1999. - Vol.96. -N. 17.-P. 9563-9567
Lock R. B, Bcl-2 inhibits a Fas induced conformational change in the Bax N-terminus and Bax mitochondrial translocation // The journal of biological chemistry. -2000. - Vol. 275. -N. 23. - P. 17225-17228
Lorenz HM., Herrmann M, Winkler Т., et al. Role of apoptosis in autoimmunity//Apoptosis. - 2000. -Vol. 5. - P. 443
Lynch DH., Ramsdell F., Alderson MR. Fas and FasL in the homeostatic regulation of immune responses// Immunol Today. -1995. -Vol. 16. - P.569
MacFarlane M., Merrison W., Bratton S. B. et al. Proteasome-mediated degradation of Smac during fpoptosis: XIAP promotes Smac ubiquitination in vitro // The journal of biological chemistry. - 2002. - Vol. 277. - P. 36611-36616
Marani M., Tenev Т., Hancock D, et al. Identification of novel isoforms of the BH3 domain protein Bim which directly activate Bax to trigger apoptosis // Molecular and cellular biology. - 2002. - Vol. 22. - N. 11. - P. 3577-3589
Mathieu C., Jozan S., Mazars P. et al. Density-dependent induction of apoptosis by transforming growth factor-beta 1 in a human ovarian carcinoma cell line. Exp Cell Res 1995; 216: 1: 13-20
McDonnel J., Bechm A., Sarkiss M. et al. Importance of the Bcl-2 family in cell death regulation// Experientia. - 1996. - Vol. 52. - P. 1008-1017
Mita E, Hayashi N, Lio S et al. Role of fas ligand in apoptosis induced by hepatits С infection // Biochem. Boiphis. Res. Commun. - 1994. - 204. - P. 468-474
Mitsades N., Poulaki V.t Tseleni-Balafouta S., Koutras D.A., and Stamenkovic L Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing Ligand // Cancer Research.- 2000.- V. 60. - P. 4122-4129
Miyawaki T., Uehara T., Nibu R. et al. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol 1992; 149: 3753-3758
Mullauer L., Gruber P., Sebinger D. et al. Mutations in apoptosis genes: a pathogenetic factor for human disease // Mutat Res. - 2001. - Vol. 488. - N. 3. - P. 211-231
Nagata S. Apoptosis by death factor // Cell. - 1997. - Vol. 88. - P. 355-365
Nagata S. Fas ligand- induced apoptosis// Ann. Rev. Genet. - 1999. -Vol. 33. - P. 29-55
Nagata,S. Apoptotic DNA fragmentation.// Exp. Cell Res.-2000.-V.- 256.-P. 12–18
Narita M., Shimizu S., Ito T. et al. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome с release in isolated mitochondria // Proc. Natl. Acad. Sci. USA. - 1998. - Vol. 95. - N. 25. - P. 14681-14686
Nasir T., Arona H.S, Kaiser H.E. Apoptosis and pathogenesis of viral hepatitis C-an update in vivo.,2002.-Vol.14.-P.297-300
Nauman U., M. Weller. Retroviral BAX gene transfer fails to sensitise malignant glioma cells to CD95L-induced apoptosis and cancer chemotherapy.// Int. J. Cancer. 1998. - Vol.77. - P.645-648
Norris J.S., Hyer M.L., Voelkel-Johnson C. etal. The use of Fas Ligand, TRAIL and Bax in gene therapy of prostate cancer // Curr Gene Then- 2001,-V1(1),-P. 123-136
Okazaki M., Hino K., Fujii К et al. Hepatic Fas-antigen expression before and after interferon therapy in patients with chronic hepatitis С // Dig. Dis. Sci. - 1996. - Vol.41. - P.2453-2458
Oridate N., Lotan D., Mitchell M.F. et al. Inhibition of proliferation and induction of apoptosis in cervical carcinoma cells by retinoids: implications for chemoprevention. J Cell Biochem Suppl 1995; 23: 80-86
Ormerod M.G., O'Neill C., Robertson D. et al. cis-Diammin-edichloroplatinum(II)-induced cell death through apoptosis in sensitive and resistant human ovarian carcinoma cell lines. Cancer Chemother Pharmacol 1996; 37: 5: 463-471
Osaki M., Kase S.? Kodani I. et al. Expression of Fas and Fas ligand in human gastric adenomas and intestinal-type carcinomas: correlation with proliferation and apoptosis // Gastric cancer. - 2001. - Vol. 4. - N. 4. - P. 198-205
Owen-Shaub L. Fas/APO-1: a cell surface protein mediating apoptosis // Cancer Bull. - 1994. -Vol. 46. - P. 141-145
Pastorino J. G,, Tafani M., Rothman R. J. et al. Functional consequences of the sustained or transient activation by Bax of the mitochondrial permeability transition pore // The journal of biological chemistry. - 1999. - Vol. 274. - N. 44, - P. 31734-31739
Pastorino J.G., Chen ST., Tafani M. et al. The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition. // J. Biol. Chem. -1998. - Vol.273. - P.7770-7775
Patel T., Gores G.J., Steer C.J. Apoptosis and the liver:a mechanism of disease, growth regulation, and carcinogenesis// Hepatology. – 1999. – Vol. 30. –P. 811–815
Reed J.C. Apoptosis-based therapies // Nat. Rev. Drug Discov. - 2002. - Vol.1. -N.2.-P.H1-121
Reed J.C. Potential functions of Bcl-2 family proteins. // Advances in pharmacology. - 1997. -Vol.41. - P. 510-514
Rehermann Bs Chang K, McHutchison JG. et al Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis С virus infection//J.Clin.Invest. 1996. 98.1432-1440
Rivero V., Grespo J., Casafront F. Fulminant hepatitis by HBV. Role of Fas system. // Hepatology, —1998. —28 (Supple). —P. 482-483
Rust C., Gores G.J. Apoptosis and liver disease // Am.J. Med. – 2000. – Vol. 108. – P. 567–574
Ruvolo P.P., Deng X., May W.S. Phosphorylation of Bcl-2 and regulation of apoptosis//Leukemia.-2001.-Vol. 15.-N.4.-P. 515-522
Sacco R.L., Benson R.T., Kargman D.E., et al. // High density lipoprotein cholesterol and ischemic stroke in the elderly, The northen Manhattan stroke study. // JAMA.2003. — 60(Suppl 1) — S31-48. 49
Saegusa M., Kamata Y., Isono M., Okayasu I. Bcl-2 expression is correlated with a low apoptotic index and associated with progesterone receptor immunoreactivity in endometrial carcinomas. J Pathol 1996; 180: 3: 275-282
Sanchez-Perez A.M., Soriano S., Clarke A.R., Gaston K. Disruption of the human papillomavirus type 16 E2 gene protects cervical carcinoma cells from E2F-induced apoptosis. J Gen Virol 1997; 78 (Pt 11): 3009-3018
Sarraf С.E., Bowen I.D. Kinetic studies on a murine sarcoma and an analysis of apoptosis. Br J Cancer 1986; 54: 989-998
Schendel S. L., Xie Z., Montal M. O. et al. Channel formation by antiapoptotic protein Bcl-2 // Proc. Natl. Acad. Sci. USA. - 1997. - Vol. 94. - P. 5113-5118
Schlesinger P. H., Gross A., X.-M. Yin et al. Comparison of the ion channel characteristics of proapoptotic Bax and antiapoptotic Bcl-2 // Proc. Natl. Acad. Sci. USA. -1997. -Vol. 94. -P. 11357-11362
Sheets E.E., Crum C.P., Yeh J. Association between cervical neoplasia and apoptosis as detected by in situ nuclear labeling. Gynecol Oncol 1996; 63: 1: 94-100
Sheets E.E., Yeh J. The role of apoptosis in gynaecological malignancies. Ann Med 1997; 29: 2: 121-126
Shigekazu N. Apoptosis by death factor. Cell 1997; 88: 355-365
Shilkaitis A., Graves J., Mehta R. R. et al. Bcl-2 and Bax are differentially expressed in hyperplastic premalignant and malignant lesions of mammary carcinogenesis // Cell Growth Differ. - 2000. - Vol. 11. - P. 437-445
Shimizu S., Konishi A., Kodama T. et al, BH4 domain of antiapoptotic Bcl-2 family members closes voltage dependent anion channel and inhibits apoptotic mitochondrial changes and cell death // Proc. Natl. Acad. Sci. USA. - 2000. - Vol. 97. - N. 7. - P. 3100-3105
Shimizu S., Tsujimoto Y. Proapoptotic ВНЗ-only Bcl-2 family members induce cytochrome с release, but not mitochondnal membrane potential loss, and do not directly modulate voltage-dependent anion channel activity // Proc. Natl. Acad. Sci. USA. -2000. -VoI.97.-N. 2.-P. 577-582
Shinoura N., Yoshida Y., SadataA. et al. Apoptosis by retrovirus- and adenovirus-mediated gene transfer of Fas ligand to glioma cells; implications for gene therapy // Hum. Gene Ther. —1998. - Vol. 9, N 14. - P. 1983-1993
Shoji Y., Saegusa M., TakanoY. et al. Correlation of apoptosis with tumour cell differentiation, progression, and HPV infection in cervical carcinoma. J Clin Pathol 1996; 49: 2: 134-138
Siegel RM.,. Frederiksen J K., Zacharias D A., et al. Fas pre-association required for apoptosis signaling and dominant inhibition by pathogenic mutationsZ/Science. -2000. -Vol. 288. -P.2354-2357
Silvestrini R., Veneroni S., Daidone M. G. et al. The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node negative breast cancer patients // J. Natl. Cancer Inst. - 1994. - Vol. 86. - P. 499-504
Sinkovics J. G., Horvath J. Can virus therapy of human cancer be improved by apoptosis induction? // Med. Hypothes. —1995. - Vol. 44, N 5. - P. 359-368
Smith A.E. Gene therapy - where are we // The Lancet. - 1999. - V.354. (Suppl. l).-P. l-4
Socie G., Mary J -Y.t Lemann M. Et al.Prognostic value of apoptotic cells and infiltrating neutrophils in graft-versus-host disease of the gastrointestinal tract in humans: TNF and Fas expression // Blood. - 2004. - V. 10. - P. 50-57
Soini Y., Paakko P. Extent of apoptosis in relation to p53 and bcl-2 expression in germ cell tumors. Human Pathol 1996; 27: 11: 1221-1226
Spinozzi F., Forenza N., Agen E. et al. CD30 Th2 allergen-specific Y T lymphocytes are increased in bronchoalveolar lavage (BAL) fluid of allergic asthma patients and sensitive to steroid-induced apoptosis. Eur Resp J 1995; 8: Suppl 19: 1874
Sprinzl M.F., Rosset S., Male F.-F. et al. Chronic viral infections causes an apoptosis resistant hepatocellular phenotype by induction of regeneration factors of the liver // Strack P.R. Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2 // Proc.Natl. Acad. Sci. USA, 1996, v. 93, P. 9571-9576
Su F., Schneider R.J. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factoralpha // Proc. Natl. Acad. Sci. USA. – 1997. –Vol. 94. – P. 8744–8749
Su F., Schneider R.J. Hepatitis В virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha/TProc NatI Acad Sci 1997, 94(16), 8744-8749
Sun X.-M., Bratton S. B„ Butterworth M. et al. Bcl-2 and Bcl-XL Inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein II The journal of biological chemistry. -2002. -Vol. 277. -P. 11345-11351
Tao X.-J., Tilly K. I., Maravei D. V. Differential expression of members of the Bcl-2 gene family in proliferative and secretory human endometrium glandular epithelial cell apoptosis is associated with increased expression of Bax // Journal of clinical endocrinology and metabolism. - 1997. - Vol. 82. - N. 8. - P. P2738-P2746
Tecchio C, Huber V., Scapini P. et al. IFN-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells // Blood. - 2004. -V. 103.-P. 3837-3844
Terradillos O, Pollicino T, Lecoeur H. p53-independent apoptotic effects of the hepatitis В virus HBx protein in vivo and in vitro//Oncogene 1998, 17(16). 2115-2123
Thompson C. B. Apoptosis in the pathogenesis and treatment of disease. Science.,1995.- 5203.- 1456-1462
Tokano Y., Miyake S., Kayagaki., N et al. Soluble Fas molecule in serum of patients with systemic lupus erythematosus// J Clin immunol . -1996. -Vol.16. -P.261-265
Toubi E., Kessel A., Goldstein L. et al. Enhanced peripheral T-cell apoptosis in chronic hepatitis C virus infection: association with liver disease severity //J. Hepatol. – 2001. – Vol. 35. – P. 774–780
Trauth B.C., Klas C., Peters A.M.J. et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989; 245: 2: 301
Ueda M., Kumagai K., Ueki K. et al. Growth inhibition and apoptotic cell death in uterine cervical carcinoma cells induced by 5-fluorouracil. Int J Cancer 1997; 71: 4: 668-674
Uslu R., Jewett A., Bonavida B. Sensitization of human ovarian tumor cells by subtoxic CDDP to antifas antibody-mediated cytotoxicity and apoptosis. Gynecol Oncol 1996; 62: 2: 282-291
Vaux D.L., Strasser A. The molecular biology of apoptosis // Proc. Natl. Acad. Sci. 1996,v.93, P. 2239-2244
Wagenaar-Miller R,A,, Gorden L., Matrisian L.M. Matrix metalloproteinases in colorectal cancer: Is it worth talking about?// Cancer and metastases reviews.-2004.-V.23.-P. 119-135
Wang X. The expanding role of mitochondria in apoptosis // Genes Dev. - 2001. -Vol. 15.-N,22.-P. 2922-2933
Wang Z.H., Ding M.X., Chew S.B. et al. Bcl-2 and Bax proteins are nuclear matrix associated proteins.// Anticancer Res - 1999. - Vol.19. - P.5445-5450
Werner A.B., Vries E., Tait S.W.G. et al. Bcl-2 family member Bfl-l/Al sequesters truncated Bid to inhibit its collaboration with pro-apoptotic Bak or Bax // The journal of biological chemistry. - 2002. - Vol. 277. - P. 22781-22788
Werner A.B., Vries E., Tait S.W.G. et al. TRAIL receptor and CD95 signal to mitochondria via FADD, caspase-8/10, Bid, and Bax but differentially regulate events downstream from truncated Bid // The journal of biological chemistry. - 2002. - Vol. 277. - P. 40760-40767
Wheeler J.A., Stephens L.C., Tornos C. et al. ASTRO Research Fellowship: apoptosis as a predictor of tumor response to radiation in stage IB cervical carcinoma. American Society for Therapeutic Radiology and Oncology. Int J Radiat Oncol Biol Phys 1995; 32: 5: 1487-1493
White E. Regulation of apoptosis by transforming genes of the DNA tumor virus adenovirus//Proc. Soc. Exp. Biol. Med. 1993, 204(1), P. 30-39
Yamamoto K., Ichijo H., Korsmeyer S. J. BcI-2 is phosphorylated and inactivated by an ASKl/Jun N-terminal protein kinase pathway normally activated at G2/M // Molecular and cellular Biology. - 1999. - Vol. 19. - N. 12. - P. 8469-8478
Yamasaki F., Tokunaga O., Sugimori H. Apoptotic index in ovarian carcinoma: correlation with clinicopathologic factors and prognosis. Gynecol Oncol 1997; 66: 3: 439-448
Yang H.B., Chow N.H., Sheu B.S. et al. The role of Bcl-2 in the progression of the colorectal adenoma-carcinoma sequence // Anticancer Res. - 1999. - Vol. 19. - N. IB.-P. 727-730
Yang J., Liu X., Bhalla K. Et al. Prevention of apoptosis by Bcl-2: release of cytochrome с from mitochondria blocked // Science. - 1997. - Vol. 275. - P. 1129-1132
Yunehara S., Nishimura Y., Kishi S., Ishii A. Expression and function of apoptosis antigen Fas on T cells in thymus and peryphery. Tiss antigens 1993; 42: 4: 253
Zhang H., Holzgreve W., Geyter C. Bcl-2-L-10, a novel anti-apoptotic member of the Bcl-2 family, blocks apoptosis in the mitochondria death pathway but not in the death receptor pathway // Human Molecular Genetics. - 2001. - Vol, 10. - N. 21. - P. 2329-2339
Zhang H., Xu Q., Krajewski S. et al. Bar: An apoptosis regulator at the intersection of caspases and Bcl-2 family proteins // Proc. Natl. Acad. Sci. USA. - 2000. - Vol. 97. - P. 2597-2602
Zhu N., Khoshnan A, Schneider R. et al. Hepatitis С virus core protein binds to the cytoplasmic domain of TNF receptor 1 and enhances TNF-induced apoptosis// J.Virol. 1998, 72(5), 3691-3697
Приложение 1 Отчет о патентных исследованиях
Приложение 2
|
